RxDoctor Payments DataLook up a doctor →

VORAXAZE: payments to doctors

Payments that named VORAXAZE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$2.4M
Providers
634
Transactions
1,613
Average per transaction
$1,499

The per-transaction average — $1,499 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 634 providers the average total is $3,813, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
BTG International, Inc.$2,206,94391.3%
BTG International Inc.$194,8348.1%
Biocompatibles, Inc.$15,5760.6%
← All drugs & devices